BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
-15.67%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$3.15B
AUM Growth
+$3.15B
(-15%)
Cap. Flow
+$183M
Cap. Flow
% of AUM
5.82%
Top 10 Holdings %
Top 10 Hldgs %
73.8%
Holding
31
New
2
Increased
20
Reduced
2
Closed
3
Top Buys
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$54.8M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$40.2M |
| 3 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$34.8M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$28.5M |
| 5 |
RDUS
Radius Health, Inc.
RDUS
|
$24.3M |
Top Sells
| 1 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$126M |
| 2 |
Innoviva
INVA
|
$5.99M |
| 3 |
Theravance Biopharma
TBPH
|
$4.68M |
| 4 |
Neurocrine Biosciences
NBIX
|
$1.99M |
| 5 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$187K |
Sector Composition
| 1 | Healthcare | 83.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Prothena Corp
PRTA
$441M
| $14.5M | 0.46% |
+320,000
| New | +$14.5M |
|
|
TTPH
27
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $11.1M | 0.35% |
1,482,114
-25,000
| -2% | -$187K |
|
|
ACHN
28
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $8.84M | 0.28% |
1,279,340
| – | – |
|
|
29
Innoviva
INVA
$1.29B
| – | – |
-331,594
| Closed | -$5.99M |
|
|
30
Theravance Biopharma
TBPH
$699M
| – | – |
-359,190
| Closed | -$4.68M |
|
|
RCPT
31
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| – | – |
-665,272
| Closed | -$126M |
|